The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

Launch prices for anticancer drugs covered under Medicare Part D continue to rise, even with recent Inflation Reduction Act ...

A controversial proposal to change the Inflation Reduction Act’s pricing framework for rare disease drugs has been dropped ...

ALEXANDRIA, VA / ACCESS Newswire / June 13, 2025 / The American Society of Consultant Pharmacists (ASCP) and the National Community Pharmacists Association (NCPA) have announced joint recommendations ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...

Democrats in the House and Senate have introduced new legislation that would establish a "Part E" for Medicare, which would ...

Will Trump's move raise prices of drugs around the world? Read more at straitstimes.com. Read more at straitstimes.com.